Results of clinical trial presented on Sunday have shown that taking medicines to lower blood pressure and cholesterol failed to prevent cognitive and functional decline in older adults with moderate risk to heart disease. The study was an offshoot of a more than 12,000-patient trial called Hope-3 released earlier this year. Patients in the study with hypertension and moderate risk of heart disease slashed their long-term risk of heart attack and stroke by 40 percent by taking a blood pressure medication as well as a cholesterol-lowering statin.
Blood pressure, cholesterol drugs fail to slow cognitive decline: study